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INTRODUCTION
Accumulating data indicate that oxidative stress
(OS) plays a major role in the pathogenesis of multi-
ple sclerosis (MS). Reactive oxygen species (ROS),
leading to OS, generated in excess primarily by
macrophages, have been implicated as mediators of
demyelization and axonal damage in MS. ROS cause
damage to main cellular structures and components
such as lipids, proteins and nucleic acids (e. g.,
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RNA, DNA), resulting in cell death by necrosis or
apoptosis. In addition, weakened cellular antioxidant
defense systems in the central nervous system
(CNS) in MS, and its vulnerability to ROS effects
may augmented damage (1).
Thus, treatment with antioxidants might theoreti-
cally prevent propagation of tissue damage and im-
prove both survival and neurological outcome.
Hypothermia has long been known as a potent
putative neuroprotectant. It delays energy depletion,
reduces intracellular acidosis and ischemia, related
to the accumulation of excitotoxic neurotransmitters,
and attenuates the influx of intracellular calcium.
Additionally, hypothermia inhibits production of oxy-
gen free radicals involved in the secondary dam-
age, associated with reperfusion. It also suppresses
mechanisms of blood-brain barrier degeneration
and postischemic remodeling (2-4).
Treatment using total immersion of the body in
extremely low temperatures was first introduced
in Japan towards the end of the 1970s by Yamauchi
T (5) who constructed the first cryogenic chamber
and successfully used cryotherapy to treat rheuma-
tism.
We considered that the effects of whole body cry-
otherapy (WBCT) exposures could be associated
with increasing of antioxidative system, therefore
the purpose of this study was to compare the effects
of WBCT on changes in total antioxidative status
(TAS) of plasma and activities of the chosen antioxi-
dative enzymes in the erythrocytes of patients with




Inclusion/exclusion criteria for this study were
a diagnosis of MS and the ability to ambulate inde-
pendently. Patients with such conditions as : circu-
latory or breathing insufficiency, clotting, embolism,
inflammation of blood vessels, open wounds, ulcers,
serious cognitive disturbances, fever, addictions,
claustrophobia, and over-sensitivity to cold were ex-
cluded from the study.
The subjects (n=32) received no hormons, vita-
mins, minerals or any other substitutions with an-
tioxidative properties. None of the subjects had
previously used WBCT. Prior to the study, all the
subjects had undergone medical check-ups includ-
ing neurological and internistic examination. The
subjects were randomized into two groups (16 sub-
jects in each). Both groups were treated by program
of exercises. This includes a 20-30 min program of
progressive balance and muscle strengthening ex-
ercises. All sessions included 5 minutes warm-up
exercises. The examined group had participated ad-
ditionally to WBCT sessions. 20 healthy volunteers
were chosen to the study as a control to MS.
The protocol and procedures were done accord-
ing to the Helsinki Declaration and were approved
by Ethics Committee of the Medical University of
Lód, Poland. The study was performed in the De-
partment of Biochemistry and Rehabilitation Divi-
sion III General Hospital in Lód.
Experimental design
An experimental trial (WBCT) consisted of the
16 subjects treated by a cycle of 10 exposures in a
cryogenic chamber carried out daily from Monday
to Friday. The cryogenic chamber has two rooms :
the vestibule, with the temperature of -60, and the
main chamber, with temperature between -110
and -160. Liquid nitrogen is used as the coolant.
Sessions in the chamber lasted 2-3 min. Gregor-
owicz and Zagrobelny (6) provide guidance on the
appropriated duration of exposure and temperature
for adult patients as well as a list of medical condi-
tions in which WBCT is unsuitable.
The study was carried out in the spring 2008. Ob-
servations were made in 3 groups : I-MS patients
treated by kinesytherapy, II-MS patients immersed
by WBCT and kinesytherapy and III-healthy volun-
teers. MS patients were examined at 2 stages : at the
beginning of the treatment and at the end. Healthy
subjects had one examination.
Blood samples were collected in cooled EDTA
tubes centrifuged to isolate plasma and erythrocytes.
The specimens were taken one hour before the 10
days cycle of therapy and one hour after the last
immersion in both MS groups.
Biochemical investigations
Total Antioxidant Status (TAS) was measured in
plasma samples (healthy group and MS patients)
using the kit by Randox Laboratories Ltd.(Cat. No.
NX 2332). The plasma volume taken to estimation
was 5 μl, a total assay volume was 305 μl. The reac-
tion was carried out during 3 min. And measured
spectrophotometrically at 600 nm.
The activities of antioxidative enzymes were de-
termined in erythrocytes.
Superoxide dismutase activity in erythrocytes was
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measured according to Misra and Fridovich (7)
methods. The absorbance of the examined samples
was estimated at 380 nm using Becman spectropho-
tometer at 37. The activity was expressed as U/g
Hb.
Catalase activity in erythrocytes was determined
according to Beers and Sizer method (8). Absor-
bance was measured at 240 nm using Becman spec-
trophotometer. Enzymatic activity was expressed as
Berg Mayer units U/gHb.
Statistical analyses
Results were statistically elaborated. Due to non-
parametric distribution the Wilcoxon test was used
to analyze changes. Results were compare with
healthy subjects.
Results of TAS measured in mM were considered
statistically significant (p0,01) whereas CAT activ-
ity decreased. The results in both groups were uni-
form.
Results
Our studies have shown that the level of TAS
in MS patients is distinctly reduced compared to
healthy subjects (Fig. 1). WBCT caused statistically
significant increase of TAS in plasma of MS patients
(α=0,001) (from 0,3468 mM to 0,8126 mM) com-
pared to non WBCT MS patients (from 0,3427 mM
to 0,5266 mM) (Fig. 1 Table 1). In erytrocytes of
MS patients the level of SOD activity is significantly
Table 1 Effects of WBCT and kinesytherapy [II] with kinesytherapy [I] on TAS of plasma and activities of CuZnSOD and CAT in
the erythrocytes patients with MS
MS* Kinesytherapy [I]
(n=16)




Before After Before After
Median SD Median SD Median SD Median SD Median SD
TAS [mM] 0,29 0,22 0,43 0,3 0,25 0,3 0,76 0,35 0,65 0,4
CuZnSOD [U/gHb] 1515 310 1479 328 1434 450 1412 511 1412 511
CAT [104IU/gHb] 17,5 2,7 17,1 2,7 19,3 3,1 16,6 3,5 9,05 1,8
*multiple sclerosis
**whole body cryotherapy
Fig. 1 Comparison of total antioxidative status (TAS) activity in plasma patients with multiple sclerosis (MS) treated by whole body
cryotherapy (WBCT) and kinesytherapy [II] and only kinesytherapy [I] with healthy subjects.
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reduced compared to healthy group (Fig. 2).
We have observed that activity of CuZnSOD in
erythrocytes of MS patients after WBCT treatment
was not statistically significant change (Fig. 2 Table 1).
Contrary to activity SOD, activity of CAT was dis-
tinctly (2-fold) higher in erythrocytes of MS patients
than in healthy volunteers and exercise therapy had
no effect on CAT activity (Fig. 3 Table 1).
Fig. 2 Comparison of superoxide dismutase (CuZnSOD) activity in erythrocytes patients with multiple sclerosis (MS) treated by
whole body cryotherapy (WBCT) and kinesytherapy [II] and only kinesytherapy [I] with healthy subjects.
Fig. 3 Comparison of catalase (CAT) activity in erythrocytes patients with multiple sclerosis (MS) treated by whole body cryotherapy
(WBCT) and kinesytherapy [II], and only kinesytherapy [I] with healthy subjects.
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DISCUSSION
Oxidative stress is a hallmark of neuregenerative
disorders MS symptomatology and complications
of its negative symptoms. OS could be caused by
prolonged altered metabolism, exposure to exoge-
nous oxidizing agents or compounds and it has been
tied to inflammatory response.
The antioxidant defense system in the organism
comprises enzymatic and non enzymatic compo-
nents. The enzymatic antioxidant system includes a
variety of antioxidant enzymes such as SOD, CAT,
GPx. We observed that MS patients the activities of
erythrocyte antioxidative enzymes, specially SOD
is distinctly reduced (contrary to CAT) (Fig. 2, 3).
Antioxidants, whether synthesized endogenously
or exogenously administered are reducing agents
that neutralize the oxidative compounds (ROS) be-
fore they can cause damage to different biomole-
cules.
The measurement of TAS in plasma represents
the body redox status better than does measure of
the single circulating antioxidant.
After strenuous physical exercise, a significant in-
crease in TAS may occur (9). We observed that after
exercise MS patients TAS in plasma was increased
compared to untreated patients.
The present data demonstrate that plasma TAS
was found to be significantly lower in MS patients
than in healthy group (Fig. 1). This findings indi-
cate that an impaired antioxidant defense system
that may be dependent partly on lower activity of
SOD. It seems that the observed low level of TAS
in plasma of MS patients may be also dependent on
the low concentrations of endogenous antioxidants,
mainly uric acid. In humans, over half the antioxi-
dant capacity of blood plasma comes from uric acid.
It is known that the lower values of uric acid (194
μmol/l) have been associated with MS, whereas se-
rum uric acid in healthy subjects was290 μmol/l.
MS patients in remission reach the level of uric
acid about 230 μmol/l. Uric acid like ascorbic acid
are strong reducing agents and potent antioxidant
(10).
It should be emphasized that despite lowering ac-
tivities of CuZnSOD and CAT the total antioxidative
status significantly increased from 0,3468 mM to
0,8126 mM. Maybe that other antioxidantive en-
zymes or non enzymatic substances like GSH, glu-
tamate reductase, vitamins, microelements that can
also affect this fenomenon.
There are evidences that both cryotherapy and
moderate exercises cause increase in antioxidant
status (9-12). Similar results were found in the
study performed by Duque, et al. (13) in which
mean TAS value significantly increased 2 minutes
after the exposure to cold in the healthy man group
treated with WBCT.
Siems, et al. (14) investigated the effects of the
acute cold stimuli (winter swimming) on a number
of oxidative stress markers and showed that these
stimuli induced a decrease in the concentration of
several major plasma antioxidants (i.e. ascorbic
acid, uric acid) (14). In addition, erythrocyte level
of oxidized glutathione and the ratio of oxidized glu-
tathione/total glutathione also increased following
the cold exposure (15). The authors also indicated
the higher enzymatic protection (i.e.changes in the
activities of red blood cells catalase, glutathione per-
oxidase, superoxide dismutase) in healthy individu-
als regularly practicing winter swimming activities
compared with control subjects (16).
If protection against oxidative stress due to WBCT
treatment develops, increase in the values of TAS
observed after the exposures to cold stress should
reach the values observed in healthy subjects.
The obtained results suggest that cryotherapy
may play an important role in the process of activa-
tion of antioxidative properties in MS patients, since
the increase in the TAS was considerably greater
after using WBCT than after physical exercise.
WBCT is worth of particular concern in treatment
of patients with MS because of safety of used pro-
cedure, minimal side effects.
CONCLUSION
Our observations showed that WBCT resulted in
the increase of TAS ten days after the exposure.
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